Salvage Surgery for Initially Unresectable HCC With PVTT Converted by Locoregional Treatment Plus Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody.
Lei WangJin-Kai FengChong-De LuJia-Yi WuBin ZhouKang WangXu-Biao WeiChao LiangHong-Kun ZhouJie ShiWei-Xing GuoWan Yee LauMao-Lin YanShu-Qun ChengPublished in: The oncologist (2024)
For patients with initially unresectable HCC and PVTT who were successfully converted by the triple combination therapy, salvage liver resection may not be necessary, especially for the patients with CR or types III-IV PVTT.